Global (United States, European Union and China) Treatment for Communicable Diseases Market Research Report 2019-2025

SKU ID :QYR-13792268 | Published Date: 13-Aug-2019 | No. of pages: 116
Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Major Manufacturers Covered in This Report 1.3 Market Segment by Type 1.3.1 Global Treatment for Communicable Diseases Market Size Growth Rate by Type (2019-2025) 1.3.2 HIV 1.3.3 Influenza 1.3.4 TB 1.3.5 Malaria 1.3.6 Hepatitis 1.3.7 HPV 1.4 Market Segment by Application 1.4.1 Global Treatment for Communicable Diseases Market Share by Application (2019-2025) 1.4.2 Hospital 1.4.3 Clinic 1.4.4 Other 1.5 Study Objectives 1.6 Years Considered 2 Global Growth Trends 2.1 Global Treatment for Communicable Diseases Market Size 2.1.1 Global Treatment for Communicable Diseases Revenue 2014-2025 2.1.2 Global Treatment for Communicable Diseases Sales 2014-2025 2.2 Treatment for Communicable Diseases Growth Rate by Regions 2.2.1 Global Treatment for Communicable Diseases Sales by Regions 2014-2019 2.2.2 Global Treatment for Communicable Diseases Revenue by Regions 2014-2019 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 3 Market Share by Manufacturers 3.1 Treatment for Communicable Diseases Sales by Manufacturers 3.1.1 Treatment for Communicable Diseases Sales by Manufacturers 2014-2019 3.1.2 Treatment for Communicable Diseases Sales Market Share by Manufacturers 2014-2019 3.2 Revenue by Manufacturers 3.2.1 Treatment for Communicable Diseases Revenue by Manufacturers (2014-2019) 3.2.2 Treatment for Communicable Diseases Revenue Share by Manufacturers (2014-2019) 3.2.3 Global Treatment for Communicable Diseases Market Concentration Ratio (CR5 and HHI) 3.3 Treatment for Communicable Diseases Price by Manufacturers 3.4 Key Manufacturers Treatment for Communicable Diseases Plants/Factories Distribution and Area Served 3.5 Date of Key Manufacturers Enter into Treatment for Communicable Diseases Market 3.6 Key Manufacturers Treatment for Communicable Diseases Product Offered 3.7 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Sales and Revenue for Each Type 4.1.1 HIV Sales and Revenue (2014-2019) 4.1.2 Influenza Sales and Revenue (2014-2019) 4.1.3 TB Sales and Revenue (2014-2019) 4.1.4 Malaria Sales and Revenue (2014-2019) 4.1.5 Hepatitis Sales and Revenue (2014-2019) 4.1.6 HPV Sales and Revenue (2014-2019) 4.2 Global Treatment for Communicable Diseases Sales Market Share by Type 4.3 Global Treatment for Communicable Diseases Revenue Market Share by Type 4.4 Treatment for Communicable Diseases Price by Type 5 Market Size by Application 5.1 Overview 5.2 Global Treatment for Communicable Diseases Sales by Application 6 United States 6.1 United States Treatment for Communicable Diseases Breakdown Data by Company 6.2 United States Treatment for Communicable Diseases Breakdown Data by Type 6.3 United States Treatment for Communicable Diseases Breakdown Data by Application 7 European Union 7.1 European Union Treatment for Communicable Diseases Breakdown Data by Company 7.2 European Union Treatment for Communicable Diseases Breakdown Data by Type 7.3 European Union Treatment for Communicable Diseases Breakdown Data by Application 8 China 8.1 China Treatment for Communicable Diseases Breakdown Data by Company 8.2 China Treatment for Communicable Diseases Breakdown Data by Type 8.3 China Treatment for Communicable Diseases Breakdown Data by Application 9 Rest of World 9.1 Rest of World Treatment for Communicable Diseases Breakdown Data by Company 9.2 Rest of World Treatment for Communicable Diseases Breakdown Data by Type 9.3 Rest of World Treatment for Communicable Diseases Breakdown Data by Application 9.4 Rest of World Treatment for Communicable Diseases Breakdown Data by Countries 9.4.1 Rest of World Treatment for Communicable Diseases Sales by Countries 9.4.2 Rest of World Treatment for Communicable Diseases Revenue by Countries 9.4.3 Japan 9.4.4 Korea 9.4.5 India 9.4.6 Southeast Asia 10 Company Profiles 10.1 Novartis 10.1.1 Novartis Company Details 10.1.2 Company Description and Business Overview 10.1.3 Sales, Revenue and Market Share of Treatment for Communicable Diseases 10.1.4 Treatment for Communicable Diseases Product Introduction 10.1.5 Novartis Recent Development 10.2 Gilead 10.2.1 Gilead Company Details 10.2.2 Company Description and Business Overview 10.2.3 Sales, Revenue and Market Share of Treatment for Communicable Diseases 10.2.4 Treatment for Communicable Diseases Product Introduction 10.2.5 Gilead Recent Development 10.3 GSK 10.3.1 GSK Company Details 10.3.2 Company Description and Business Overview 10.3.3 Sales, Revenue and Market Share of Treatment for Communicable Diseases 10.3.4 Treatment for Communicable Diseases Product Introduction 10.3.5 GSK Recent Development 10.4 Janssen Pharmaceutical 10.4.1 Janssen Pharmaceutical Company Details 10.4.2 Company Description and Business Overview 10.4.3 Sales, Revenue and Market Share of Treatment for Communicable Diseases 10.4.4 Treatment for Communicable Diseases Product Introduction 10.4.5 Janssen Pharmaceutical Recent Development 10.5 Roche 10.5.1 Roche Company Details 10.5.2 Company Description and Business Overview 10.5.3 Sales, Revenue and Market Share of Treatment for Communicable Diseases 10.5.4 Treatment for Communicable Diseases Product Introduction 10.5.5 Roche Recent Development 10.6 BioCryst Pharmaceuticals 10.6.1 BioCryst Pharmaceuticals Company Details 10.6.2 Company Description and Business Overview 10.6.3 Sales, Revenue and Market Share of Treatment for Communicable Diseases 10.6.4 Treatment for Communicable Diseases Product Introduction 10.6.5 BioCryst Pharmaceuticals Recent Development 10.7 Merck 10.7.1 Merck Company Details 10.7.2 Company Description and Business Overview 10.7.3 Sales, Revenue and Market Share of Treatment for Communicable Diseases 10.7.4 Treatment for Communicable Diseases Product Introduction 10.7.5 Merck Recent Development 10.8 Boehringer Ingelheim 10.8.1 Boehringer Ingelheim Company Details 10.8.2 Company Description and Business Overview 10.8.3 Sales, Revenue and Market Share of Treatment for Communicable Diseases 10.8.4 Treatment for Communicable Diseases Product Introduction 10.8.5 Boehringer Ingelheim Recent Development 11 Value Chain and Sales Channels Analysis 11.1 Value Chain Analysis 11.2 Sales Channels Analysis 11.2.1 Treatment for Communicable Diseases Sales Channels 11.2.2 Treatment for Communicable Diseases Distributors 11.3 Treatment for Communicable Diseases Customers 12 Market Forecast 12.1 Global Treatment for Communicable Diseases Sales and Revenue Forecast 2019-2025 12.2 Global Treatment for Communicable Diseases Sales Forecast by Type 12.3 Global Treatment for Communicable Diseases Sales Forecast by Application 12.4 Treatment for Communicable Diseases Forecast by Regions 12.4.1 Global Treatment for Communicable Diseases Sales Forecast by Regions 2019-2025 12.4.2 Global Treatment for Communicable Diseases Revenue Forecast by Regions 2019-2025 12.5 United States Market Forecast 12.6 European Union Market Forecast 12.7 China Market Forecast 12.8 Rest of World 12.8.1 Japan 12.8.2 Korea 12.8.3 India 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.1.1 Research Programs/Design 14.1.1.2 Market Size Estimation 14.1.1.3 Market Breakdown and Data Triangulation 14.1.2 Data Source 14.1.2.1 Secondary Sources 14.1.2.2 Primary Sources 14.2 Author Details 14.3 Disclaimer
List of Tables and Figures Figure Treatment for Communicable Diseases Product Picture Table Treatment for Communicable Diseases Key Market Segments Table Major Manufacturers Treatment for Communicable Diseases Covered in This Report Table Global Treatment for Communicable Diseases Market Size Growth Rate by Type 2019-2025 (K Units) & (Million US$) Figure Global Treatment for Communicable Diseases Sales Market Shar by Type 2014-2025 Figure HIV Figures Table Major Manufacturers of HIV Figure Influenza Figures Table Major Manufacturers of Influenza Figure TB Figures Table Major Manufacturers of TB Figure Malaria Figures Table Major Manufacturers of Malaria Figure Hepatitis Figures Table Major Manufacturers of Hepatitis Figure HPV Figures Table Major Manufacturers of HPV Table Global Treatment for Communicable Diseases Market Share by Application 2019-2025 (K Units) Figure Hospital Use Case Figure Clinic Use Case Figure Other Use Case Figure Treatment for Communicable Diseases Report Years Considered Figure Global Treatment for Communicable Diseases Market Size 2014-2025 (Million US$) Figure Global Treatment for Communicable Diseases Sales 2014-2019 (K Units) Table Global Treatment for Communicable Diseases Market Size by Regions 2014-2019 (K Units) & (Million US$) Table Global Treatment for Communicable Diseases Sales by Regions 2014-2019 (K Units) Table Global Treatment for Communicable Diseases Sales Market Share by Regions 2014-2019 Figure Global Treatment for Communicable Diseases Sales Market Share by Regions 2014-2019 Figure Global Treatment for Communicable Diseases Sales Market Share by Regions in 2019 Table Global Treatment for Communicable Diseases Revenue by Regions 2014-2019 (Million US$) Table Global Treatment for Communicable Diseases Revenue Market Share by Regions 2014-2019 Figure Global Treatment for Communicable Diseases Revenue Market Share by Regions 2014-2019 Figure Global Treatment for Communicable Diseases Revenue Market Share by Regions in 2019 Table Market Top Trends Table Global Treatment for Communicable Diseases Sales by Manufacturers (2014-2019) (K Units) Table Global Treatment for Communicable Diseases Sales Share by Manufacturers (2014-2019) Figure Global Treatment for Communicable Diseases Sales Share by Manufacturers in 2019 Table Treatment for Communicable Diseases Revenue by Manufacturers (2014-2019) (Million USD) Table Treatment for Communicable Diseases Revenue Share by Manufacturers (2014-2019) Figure Treatment for Communicable Diseases Value Share by Manufacturers in 2019 Table Global Treatment for Communicable Diseases Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Manufacturers Treatment for Communicable Diseases Price (2014-2019) (USD/Unit) Table Key Manufacturers Treatment for Communicable Diseases Plants/Factories Distribution Table Key Manufacturers Treatment for Communicable Diseases Area Served Table Date of Key Manufacturers Enter into Treatment for Communicable Diseases Market Table Key Manufacturers Treatment for Communicable Diseases Product Type Table Mergers & Acquisitions, Expansion Plans Table Global HIV Sales and Revenue (2014-2019) (K Units) & (Million US$) Table Global Influenza Sales and Revenue (2014-2019) (K Units) & (Million US$) Table Global TB Sales and Revenue (2014-2019) (K Units) & (Million US$) Table Global Malaria Sales and Revenue (2014-2019) (K Units) & (Million US$) Table Global Hepatitis Sales and Revenue (2014-2019) (K Units) & (Million US$) Table Global HPV Sales and Revenue (2014-2019) (K Units) & (Million US$) Table Global Treatment for Communicable Diseases Sales by Type (2014-2019) (K Units) Table Global Treatment for Communicable Diseases Sales Share by Type (2014-2019) Figure Global Treatment for Communicable Diseases Sales Market Share by Type (2014-2019) Figure Global Treatment for Communicable Diseases Sales Market Share by Type in 2018 Table Global Treatment for Communicable Diseases Revenue by Type (2014-2019) (Million US$) Table Global Treatment for Communicable Diseases Revenue Share by Type (2014-2019) Figure Global Treatment for Communicable Diseases Revenue Market Share by Type (2014-2019) Figure Global Treatment for Communicable Diseases Revenue Market Share by Type in 2018 Table Treatment for Communicable Diseases Price by Type 2014-2019 (USD/Unit) Table Global Treatment for Communicable Diseases Sales by Application (2014-2019) (K Units) Table Global Treatment for Communicable Diseases Sales Share by Application (2014-2019) Figure Global Sales Treatment for Communicable Diseases Market Share by Application (2014-2019) Figure Global Sales Treatment for Communicable Diseases Market Share by Application (2014-2019) Figure United States Treatment for Communicable Diseases Sales Growth Rate 2014-2019 (K Units) Figure United States Treatment for Communicable Diseases Revenue Growth Rate 2014-2019 (Million US$) Table United States Treatment for Communicable Diseases Sales by Company (2014-2019) (K Units) Table United States Treatment for Communicable Diseases Sales Market Share by Company (2014-2019) Figure United States Treatment for Communicable Diseases Sales Market Share by Company in 2019 Table United States Treatment for Communicable Diseases Sales by Type (2014-2019) (K Units) Table United States Treatment for Communicable Diseases Sales Market Share by Type (2014-2019) Figure United States Treatment for Communicable Diseases Market Share by Type in 2019 Table United States Treatment for Communicable Diseases Sales by Application (2014-2019) (K Units) Table United States Treatment for Communicable Diseases Sales Market Share by Application (2014-2019) Figure United States Treatment for Communicable Diseases Market Share by Application in 2019 Figure European Union Treatment for Communicable Diseases Sales Growth Rate 2014-2019 (K Units) Figure European Union Treatment for Communicable Diseases Revenue Growth Rate 2014-2019 (Million US$) Table European Union Treatment for Communicable Diseases Sales by Company (2014-2019) (K Units) Table European Union Treatment for Communicable Diseases Sales Market Share by Company (2014-2019) Figure European Union Treatment for Communicable Diseases Sales Market Share by Company in 2019 Table European Union Treatment for Communicable Diseases Sales by Type (2014-2019) (K Units) Table European Union Treatment for Communicable Diseases Sales Market Share by Type (2014-2019) Figure 2018 European Union Treatment for Communicable Diseases Market Share by Type Table European Union Treatment for Communicable Diseases Sales by Application (2014-2019) (K Units) Table European Union Treatment for Communicable Diseases Sales Market Share by Application (2014-2019) Figure 2018 European Union Treatment for Communicable Diseases Market Share by Application Figure China Treatment for Communicable Diseases Sales Growth Rate 2014-2019 (K Units) Figure China Treatment for Communicable Diseases Revenue Growth Rate 2014-2019 (Million US$) Table China Treatment for Communicable Diseases Sales by Company (2014-2019) (K Units) Table China Treatment for Communicable Diseases Sales Market Share by Company (2014-2019) Figure China Treatment for Communicable Diseases Sales Market Share by Company in 2019 Table China Treatment for Communicable Diseases Sales by Type (2014-2019) (K Units) Table China Treatment for Communicable Diseases Sales Market Share by Type (2014-2019) Figure China Treatment for Communicable Diseases Market Share by Type in 2019 Table China Treatment for Communicable Diseases Sales by Application (2014-2019) (K Units) Table China Treatment for Communicable Diseases Sales Market Share by Application (2014-2019) Figure China Treatment for Communicable Diseases Market Share by Application in 2019 Figure Rest of World Treatment for Communicable Diseases Sales Growth Rate 2014-2019 (K Units) Figure Rest of World Treatment for Communicable Diseases Revenue Growth Rate 2014-2019 (Million US$) Table Rest of World Treatment for Communicable Diseases Sales by Company (2014-2019) (K Units) Table Rest of World Treatment for Communicable Diseases Sales Market Share by Company (2014-2019) Figure Rest of World Treatment for Communicable Diseases Sales Market Share by Company in 2019 Table Rest of World Treatment for Communicable Diseases Sales by Type (2014-2019) (K Units) Table Rest of World Treatment for Communicable Diseases Sales Market Share by Type (2014-2019) Figure Rest of World Treatment for Communicable Diseases Market Share by Type in 2019 Table Rest of World Treatment for Communicable Diseases Sales by Application (2014-2019) (K Units) Table Rest of World Treatment for Communicable Diseases Sales Market Share by Application (2014-2019) Figure Rest of World Treatment for Communicable Diseases Market Share by Application in 2019 Table Rest of World Treatment for Communicable Diseases Sales by Countries (2014-2019) (K Units) Table Rest of World Treatment for Communicable Diseases Sales Market Share by Countries (2014-2019) Figure Rest of World Treatment for Communicable Diseases Sales Market Share by Countries in 2019 Table Rest of World Treatment for Communicable Diseases Revenue by Countries (2014-2019) (Million US$) Table Rest of World Treatment for Communicable Diseases Revenue Market Share by Countries (2014-2019) Figure Rest of World Treatment for Communicable Diseases Revenue Market Share by Countries in 2019 Figure Japan Treatment for Communicable Diseases Sales Growth Rate (2014-2019) (K Units) Figure Japan Treatment for Communicable Diseases Revenue Growth Rate (2014-2019) (K Units) Figure Korea Treatment for Communicable Diseases Sales Growth Rate (2014-2019) (K Units) Figure Korea Treatment for Communicable Diseases Revenue Growth Rate (2014-2019) (K Units) Figure India Treatment for Communicable Diseases Sales Growth Rate (2014-2019) (K Units) Figure India Treatment for Communicable Diseases Revenue Growth Rate (2014-2019) (K Units) Figure Southeast Asia Treatment for Communicable Diseases Sales Growth Rate (2014-2019) (K Units) Figure Southeast Asia Treatment for Communicable Diseases Revenue Growth Rate (2014-2019) (K Units) Table Novartis Company Details Table Novartis Description and Business Overview Table Novartis Treatment for Communicable Diseases Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table Novartis Treatment for Communicable Diseases Sales Growth Rate (2014-2019) Table Novartis Treatment for Communicable Diseases Sales Market Share in Global Market Table Novartis Recent Development Table Gilead Company Details Table Gilead Description and Business Overview Table Gilead Treatment for Communicable Diseases Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table Gilead Treatment for Communicable Diseases Sales Growth Rate (2014-2019) Table Gilead Treatment for Communicable Diseases Sales Market Share in Global Market Table Gilead Recent Development Table GSK Company Details Table GSK Description and Business Overview Table GSK Treatment for Communicable Diseases Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table GSK Treatment for Communicable Diseases Sales Growth Rate (2014-2019) Table GSK Treatment for Communicable Diseases Sales Market Share in Global Market Table GSK Recent Development Table Janssen Pharmaceutical Company Details Table Janssen Pharmaceutical Description and Business Overview Table Janssen Pharmaceutical Treatment for Communicable Diseases Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table Janssen Pharmaceutical Treatment for Communicable Diseases Sales Growth Rate (2014-2019) Table Janssen Pharmaceutical Treatment for Communicable Diseases Sales Market Share in Global Market Table Janssen Pharmaceutical Recent Development Table Roche Company Details Table Roche Description and Business Overview Table Roche Treatment for Communicable Diseases Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table Roche Treatment for Communicable Diseases Sales Growth Rate (2014-2019) Table Roche Treatment for Communicable Diseases Sales Market Share in Global Market Table Roche Recent Development Table BioCryst Pharmaceuticals Company Details Table BioCryst Pharmaceuticals Description and Business Overview Table BioCryst Pharmaceuticals Treatment for Communicable Diseases Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table BioCryst Pharmaceuticals Treatment for Communicable Diseases Sales Growth Rate (2014-2019) Table BioCryst Pharmaceuticals Treatment for Communicable Diseases Sales Market Share in Global Market Table BioCryst Pharmaceuticals Recent Development Table Merck Company Details Table Merck Description and Business Overview Table Merck Treatment for Communicable Diseases Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table Merck Treatment for Communicable Diseases Sales Growth Rate (2014-2019) Table Merck Treatment for Communicable Diseases Sales Market Share in Global Market Table Merck Recent Development Table Boehringer Ingelheim Company Details Table Boehringer Ingelheim Description and Business Overview Table Boehringer Ingelheim Treatment for Communicable Diseases Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table Boehringer Ingelheim Treatment for Communicable Diseases Sales Growth Rate (2014-2019) Table Boehringer Ingelheim Treatment for Communicable Diseases Sales Market Share in Global Market Table Boehringer Ingelheim Recent Development Figure Treatment for Communicable Diseases Value Chain Table Treatment for Communicable Diseases Distributors List Table Treatment for Communicable Diseases Customers List Table Global Treatment for Communicable Diseases Sales Forecast 2019-2025 (K Units) & (Million US$) Figure Global Treatment for Communicable Diseases Sales Forecast 2019-2025 (K Units) Figure Global Treatment for Communicable Diseases Revenue Forecast 2019-2025 (Million US$) Table Global Treatment for Communicable Diseases Sales Forecast by Type 2019-2025 (K Units) Figure Global Treatment for Communicable Diseases Sales Forecast by Type 2019-2025 (K Units) Figure Global Treatment for Communicable Diseases Sales Market Share Forecast by Type 2019-2025 Table Global Treatment for Communicable Diseases Sales Forecast by Application 2019-2025 (K Units) Figure Global Treatment for Communicable Diseases Sales Forecast by Application 2019-2025 (K Units) Figure Global Treatment for Communicable Diseases Sales Market Share Forecast by Application 2019-2025 Table Global Treatment for Communicable Diseases Sales Forecast by Regions 2019-2025 (K Units) Figure Global Treatment for Communicable Diseases Sales Forecast by Regions 2019-2025 (K Units) Figure Global Treatment for Communicable Diseases Sales Market Share Forecast by Regions 2019-2025 Table Global Treatment for Communicable Diseases Revenue Forecast by Regions 2019-2025 (K Units) Figure Global Treatment for Communicable Diseases Revenue Forecast by Regions 2019-2025 (K Units) Figure Global Treatment for Communicable Diseases Revenue Market Share Forecast by Regions 2019-2025 Figure United States Treatment for Communicable Diseases Sales Forecast 2019-2025 (K Units) Figure United States Treatment for Communicable Diseases Revenue Forecast 2019-2025 (Million US$) Figure European Union Treatment for Communicable Diseases Sales Forecast 2019-2025 (K Units) Figure European Union Treatment for Communicable Diseases Revenue Forecast 2019-2025 (Million US$) Figure China Treatment for Communicable Diseases Sales Forecast 2019-2025 (K Units) Figure China Treatment for Communicable Diseases Revenue Forecast 2019-2025 (Million US$) Figure Japan Treatment for Communicable Diseases Sales Forecast 2019-2025 (K Units) Figure Japan Treatment for Communicable Diseases Revenue Forecast 2019-2025 (Million US$) Figure Korea Treatment for Communicable Diseases Sales Forecast 2019-2025 (K Units) Figure Korea Treatment for Communicable Diseases Revenue Forecast 2019-2025 (Million US$) Figure India Treatment for Communicable Diseases Sales Forecast 2019-2025 (K Units) Figure India Treatment for Communicable Diseases Revenue Forecast 2019-2025 (Million US$) Figure Southeast Asia Treatment for Communicable Diseases Sales Forecast 2019-2025 (K Units) Figure Southeast Asia Treatment for Communicable Diseases Revenue Forecast 2019-2025 (Million US$) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources
Novartis Gilead GSK Janssen Pharmaceutical Roche BioCryst Pharmaceuticals Merck Boehringer Ingelheim
  • PRICE
  • $3280
    $6560

Our Clients